Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Background: The double-blind, 2 × 2 factorial design, placebo-controlled ASCEND randomized trial compared the effects of 100 mg aspirin daily and, separately, 1 g omega-3 fatty acids (FAs) daily on the primary prevention of cardiovascular disease in 15,480 UK adults with diabetes. We report the effe...
Prif Awduron: | Sammons, EL, Buck, G, Bowman, LJ, Stevens, WM, Hammami, I, Parish, S, Armitage, J |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BioMed Central
2024
|
Eitemau Tebyg
-
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
gan: Sammons, EL, et al.
Cyhoeddwyd: (2024) -
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
gan: Emily L. Sammons, et al.
Cyhoeddwyd: (2024-11-01) -
ASCEND-Eye: effects of aspirin on diabetic retinopathy
gan: Sammons, E, et al.
Cyhoeddwyd: (2024) -
ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
gan: Sammons, E, et al.
Cyhoeddwyd: (2023) -
ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
gan: Sammons, E, et al.
Cyhoeddwyd: (2023)